Trial Profile
A phase I trial to investigate the effect of recombinant malaria vaccine.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 06 Dec 2023
Price :
$35
*
At a glance
- Drugs Px 533 (Primary)
- Indications Malaria
- Focus Adverse reactions
- 30 Mar 2015 New trial record
- 16 Mar 2015 According to Pfenex media release, company is planning to initiate this trial in 2015.